TY - JOUR
T1 - Screening, diagnosis and management of human cysticercosis and Taenia solium taeniasis
T2 - technical recommendations by the COHEMI project study group
AU - The COHEMI Project Study Group
AU - Zammarchi, Lorenzo
AU - Bonati, Maurizio
AU - Strohmeyer, Marianne
AU - Albonico, Marco
AU - Requena-Méndez, Ana
AU - Bisoffi, Zeno
AU - Nicoletti, Alessandra
AU - García, Hector H.
AU - Bartoloni, Alessandro
AU - Pandolfini, Chiara
AU - Severino, Francesca
AU - Confalonieri, Valeria
AU - Tognoni, Gianni
AU - Buonfrate, Dora
AU - Angheben, Andrea
AU - Bartalesi, Filippo
AU - Muñoz, Jose
AU - Roura, Maria
AU - Ventura, Laia
AU - Pool, Robert
AU - Pell, Christopher
AU - Hardon, Anita
AU - Chiodini, Peter
AU - Moreira, Juan
AU - Anselmi, Mariella
AU - Sempértegui, Roberto
AU - Gotuzzo, Eduardo
AU - Mena, Maria Alejandra
AU - Liendo, Carola
AU - Bustos, Javier
AU - Santivañez, Saul
AU - Torrico, Faustino
AU - Lozano, Daniel
AU - Cabrera, Teresa Hinojosa
AU - Morón, Javier Ochoa
AU - Cuellar, Ignacio Abapori
AU - Suarez, Jaime Amorós
AU - Rojas, Guido Chumiray
AU - Bruno, Elisa
N1 - Funding Information:
This work has been supported by the EC within the 7th Framework Program under grant agreement no. FP7-GA-261495. We thank Miss Elizabeth Cavanaugh Vincent for proofreading and English corrections and the COHEMI (COordinating resources to assess and improve HEalth status of MIgrants from Latin America)-project study group that includes: Maurizio Bonatia, Chiara Pandolfinia, Francesca Severinoa, Valeria Confalonieria, Gianni Tognonia, Zeno Bisoffib, Dora Buonfrateb, Andrea Anghebenb, Marco Albonicob, Alessandro Bartolonic, Marianne Strohmeyerc, Lorenzo Zammarchic, Filippo Bartalesid, Jose Muñoze, Ana Requena-Mendeze, Maria Rourae, Laia Venturae, Robert Poolf, Christopher Pellf, Anita Hardonf, Peter Chiodinig, Juan Moreirah, Mariella Anselmih, Roberto Sempérteguih, Eduardo Gotuzzoi, Maria Alejandra Menai, Carola Liendoi, Héctor H. Garciaj, Javier Bustosj, Saul Santivañezj, Faustino Torricok, Daniel Lozanok, Teresa Hinojosa Cabreral, Javier Ochoa Morónl, Ignacio Abapori Cuellarl, Jaime Amorós Suarezl, Guido Chumiray Rojasl, Alessandra Nicolettim, Elisa Brunom. aDepartment of Public Health, Laboratory for Mother and Child Health, IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy. bCentre for Tropical Diseases, Sacro Cuore-Don Calabria Hospital, Negrar, Verona, Italy. cInfectious Disease Unit, Department of Experimental & Clinical Medicine, University of Florence School of Medicine, Florence, Italy. dSOD Malattie Infettive e Tropicali, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy. eServicio de Medicina Tropical y Salud Internacional, Centre de Recerca en Salut Internacional de Barcelona, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain. fCentre for Social Science and Global Health, University of Amsterdam, The Netherlands. gHospital for Tropical Diseases and London School of Hygiene & Tropical Medicine, London, United Kingdom. hCentre for Community Epidemiology and Tropical Medicine, Esmeraldas, Ecuador. iInstituto de Medicina Tropical Alexander von Humboldt, Universidad Cayetano Heredia, Lima, Peru. jCysticercosis Unit, Instituto de Ciencias Neurológicas, Department of Microbiology, Universidad Peruana Cayetano Heredia, Lima, Peru. kColectivo de Estudios Aplicados y Desarrollo Social, Cochabamba, Bolivia. lTaller de Educación y Comunicación TEKO-GUARANÌ, Camiri, Bolivia. mDipartimento G.F. Ingrassia Sezione di Neuroscienze, Università di Catania, Catania, Italy.
Publisher Copyright:
© 2017 John Wiley & Sons Ltd
PY - 2017/7/1
Y1 - 2017/7/1
N2 - Neurocysticercosis, the central nervous system's localised form of cysticercosis, is considered to be the leading cause of epilepsy in the developing world. In Europe, the disease is mainly imported and affects both immigrants and travellers. However, autochthonous cases of cysticercosis in low-endemic countries could also originate from Taenia solium carriers (migrants or travellers) who acquired taeniasis overseas. Management of cysticercosis is a challenge for European healthcare providers as they are often hardly aware of this infection and have little familiarity in managing this disease. This study provides a summary of recommendations concerning screening, diagnosis and management of cysticercosis and T. solium taeniasis in Europe drawn up by nine experts in migrant health and imported diseases with experience in cysticercosis and T. solium taeniasis.
AB - Neurocysticercosis, the central nervous system's localised form of cysticercosis, is considered to be the leading cause of epilepsy in the developing world. In Europe, the disease is mainly imported and affects both immigrants and travellers. However, autochthonous cases of cysticercosis in low-endemic countries could also originate from Taenia solium carriers (migrants or travellers) who acquired taeniasis overseas. Management of cysticercosis is a challenge for European healthcare providers as they are often hardly aware of this infection and have little familiarity in managing this disease. This study provides a summary of recommendations concerning screening, diagnosis and management of cysticercosis and T. solium taeniasis in Europe drawn up by nine experts in migrant health and imported diseases with experience in cysticercosis and T. solium taeniasis.
KW - Taenia solium
KW - cysticercosis
KW - epilepsy
KW - neurocysticercosis
KW - recommendations
KW - taeniasis
UR - http://www.scopus.com/inward/record.url?scp=85020073135&partnerID=8YFLogxK
U2 - 10.1111/tmi.12887
DO - 10.1111/tmi.12887
M3 - Original Article
C2 - 28449318
AN - SCOPUS:85020073135
SN - 1360-2276
VL - 22
SP - 881
EP - 894
JO - Tropical Medicine and International Health
JF - Tropical Medicine and International Health
IS - 7
ER -